John H. McVey

John H. McVey

Auto-generated profile, based on publicly available information

John H. McVey

School of Biosciences, University of Surrey, Guildford, UK

Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2008 in Cell
Verified
Journal Article
Closed access
SWSimon Waddington
Simon Waddington
JMJohn H. McVey
John H. McVey
DBDavid Bhella
David Bhella
Alan ParkerAlan Parker
Alan Parker
KBKristeen Barker
Kristeen Barker
Andy BakerAndy Baker
Andy Baker

25 April 2013 in Blood
Verified
Journal Article
Open access
PDF file
JMJenny McIntosh
Jenny McIntosh
PLPeter J. Lenting
Peter J. Lenting
CRCecilia Rosales
Cecilia Rosales
DLDoyoung Lee
Doyoung Lee
SRSamira Rabbanian
Samira Rabbanian
ANAmit C. Nathwani
Amit C. Nathwani
Key Points: Novel, more potent codon-optimized human FVIII variant (codop-hFVIII-V3). Codop-hFVIII-V3 is safe and efficacious in mice and nonhuman primates, thus improving the prospects of gene therapy for hemophilia A.

28 April 2003 in Nature Genetics
Verified
Journal Article
Closed access
BZBin Zhang
Bin Zhang
MCMichael A Cunningham
Michael A Cunningham
WNWilliam C Nichols
William C Nichols
JBJohn A. Bernat
John A. Bernat
USUri Seligsohn
Uri Seligsohn
DGDavid Ginsburg
David Ginsburg

1 July 1987 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
PHP W Holland
P W Holland
SHS J Harper
S J Harper
JMJ H McVey
J H McVey
BHB L Hogan
B L Hogan
In situ hybridization is used to survey the tissue-specific and developmental expression of the cloned mouse gene Sparc, coding for a protein homologous to the bovine Ca++-binding protein, osteonectin. High levels of SPARC RNA are found in osteoblasts and odontoblasts. In addition, high grain counts are associated with a variety of other cell types in the embryo and newborn mouse, including parietal endoderm, deciduum, whisker follicles (connective tissue sheath), peripheral nerve trunk, skin (dermis), and stomach (submucosa). Spatially restricted but high levels of SPARC mRNA are also seen in the adult adrenal glands, testis, and ovary. This pattern of differential gene expression demands a reassessment of the function originally proposed for osteonectin, and predicts a much wider role for the protein in a variety of biological processes.

15 October 2006 in Blood
Verified
Journal Article
Closed access
PDF file
Alan ParkerAlan Parker
Alan Parker
SWSimon Waddington
Simon Waddington
CNCampbell G. Nicol
Campbell G. Nicol
DSDmitry M. Shayakhmetov
Dmitry M. Shayakhmetov
SBSuzanne M. Buckley
Suzanne M. Buckley
Andy BakerAndy Baker
Andy Baker
Upon local delivery, adenovirus (Ad) serotype 5 viruses use the coxsackie and Ad receptor (CAR) for cell binding and αv integrins for internalization. When administered systemically, however, their role in liver tropism is limited because CAR-permissive and mutated viruses show similar biodistribution, a finding recently attributed to blood coagulation factor (F) IX or complement protein C4BP binding to the adenovirus fiber and “bridging” to either low-density lipoprotein receptor-related protein or heparan sulfate proteoglycans. Here, we show that hepatocyte transduction in vitro can be enhanced by the vitamin K-dependent factors FX, protein C, and FVII in addition to FIX but not by prothrombin (FII), FXI, and FXII. This phenomenon was not dependent on proteolytic activation or cell signaling activity and for FX was mediated by direct virus-factor binding. Human FX substantially enhanced hepatocyte transduction by CAR-permissive and mutated viruses in an ex vivo liver perfusion model. In vivo, global down-regulation of vitamin K-dependent zymogens by warfarin significantly diminished liver uptake of CAR-deleted Ads; however, this phenomenon was fully rescued by acute infusion of human FX. Our results indicate a common and pivotal role for distinct vitamin K-dependent coagulation factors in mediating hepatocyte transduction by adenoviruses in vitro and in vivo.

20 January 2011 in Blood
Verified
Journal Article
Open access
PDF file
NWNatalie J. Ward
Natalie J. Ward
SBSuzanne M. K. Buckley
Suzanne M. K. Buckley
SWSimon Waddington
Simon Waddington
TVThierry VandenDriessche
Thierry VandenDriessche
MCMarinee K. L. Chuah
Marinee K. L. Chuah
JMJohn H. McVey
John H. McVey
Gene therapy for hemophilia A would be facilitated by development of smaller expression cassettes encoding factor VIII (FVIII), which demonstrate improved biosynthesis and/or enhanced biologic properties. B domain deleted (BDD) FVIII retains full procoagulant function and is expressed at higher levels than wild-type FVIII. However, a partial BDD FVIII, leaving an N-terminal 226 amino acid stretch (N6), increases in vitro secretion of FVIII tenfold compared with BDD-FVIII. In this study, we tested various BDD constructs in the context of either wild-type or codon-optimized cDNA sequences expressed under control of the strong, ubiquitous Spleen Focus Forming Virus promoter within a self-inactivating HIV-based lentiviral vector. Transduced 293T cells in vitro demonstrated detectable FVIII activity. Hemophilic mice treated with lentiviral vectors showed expression of FVIII activity and phenotypic correction sustained over 250 days. Importantly, codon-optimized constructs achieved an unprecedented 29- to 44-fold increase in expression, yielding more than 200% normal human FVIII levels. Addition of B domain sequences to BDD-FVIII did not significantly increase in vivo expression. These significant findings demonstrate that shorter FVIII constructs that can be more easily accommodated in viral vectors can result in increased therapeutic efficacy and may deliver effective gene therapy for hemophilia A.